WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹121 Cr | ₹94 Cr | ₹93 Cr | ₹125 Cr | ₹96 Cr |
What is the latest Total Current Liabilities ratio of WINDLAS BIOTECH ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹121 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹93 Cr |
Mar2020 | ₹125 Cr |
Mar2019 | ₹96 Cr |
How is Total Current Liabilities of WINDLAS BIOTECH Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹121 Cr | 29.00 | |
Mar2022 | ₹94 Cr | 0.61 | |
Mar2021 | ₹93 Cr | -25.44 | |
Mar2020 | ₹125 Cr | 30.22 | |
Mar2019 | ₹96 Cr | - |
Compare Total Current Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹1,148.0 Cr | -1.4% | 6.8% | 118.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,512.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -1.4% |
6.8% |
118.9% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses